tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PRFX Stock Latest News

PainReform files patent covering manufacturing process for PRF-110
The FlyPainReform files patent covering manufacturing process for PRF-110
4d ago
PRFX
PainReform Announces Crucial Shareholders Meeting
PremiumCompany Announcements
PainReform Announces Crucial Shareholders Meeting
19d ago
6K
PRFX
PainReform Advances Non-Opioid Pain Solution Trial
PremiumCompany Announcements
PainReform Advances Non-Opioid Pain Solution Trial
1M ago
6K
PRFX
PainReform completes enrollment in second part of Phase 3 trial of PRF-110
PremiumThe Fly
PainReform completes enrollment in second part of Phase 3 trial of PRF-110
1M ago
PRFX
PainReform Faces Nasdaq Compliance Challenge
PremiumCompany Announcements
PainReform Faces Nasdaq Compliance Challenge
2M ago
6K
PRFX
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
PremiumPress ReleasesPainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
2M ago
PRFX
Painreform Ltd. Q1 Financials Show Asset Decline
PremiumCompany Announcements
Painreform Ltd. Q1 Financials Show Asset Decline
2M ago
6K
PRFX
PainReform Provides Business Update for the First Quarter of 2024
PremiumPress Releases
PainReform Provides Business Update for the First Quarter of 2024
2M ago
PRFX
PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com
PremiumPress Releases
PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com
3M ago
PRFX
PainReform Announces Closing of $4 Million Public Offering
PremiumPress Releases
PainReform Announces Closing of $4 Million Public Offering
3M ago
PRFX
PainReform Ltd. Adjusts Warrant Terms
PremiumCompany Announcements
PainReform Ltd. Adjusts Warrant Terms
3M ago
6K
PRFX
PainReform Ltd. Launches $4 Million Public Offering
PremiumCompany Announcements
PainReform Ltd. Launches $4 Million Public Offering
3M ago
6K
PRFX
PainReform prices 5M shares at 80c in public offering
PremiumThe FlyPainReform prices 5M shares at 80c in public offering
3M ago
PRFX
PainReform’s PRF-110 Sets New Pain Relief Benchmark
PremiumCompany Announcements
PainReform’s PRF-110 Sets New Pain Relief Benchmark
4M ago
6K
PRFX
PainReform says IVR rates of PRF-110 superior for post-surgical pain products
PremiumThe Fly
PainReform says IVR rates of PRF-110 superior for post-surgical pain products
4M ago
PRFX
PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
PremiumPress Releases
PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
4M ago
PRFX
PainReform Shareholders Approve Key Proposals
PremiumCompany Announcements
PainReform Shareholders Approve Key Proposals
4M ago
6K
PRFX
PainReform Hits 50% Enrollment Milestone
PremiumCompany Announcements
PainReform Hits 50% Enrollment Milestone
4M ago
6K
PRFX
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy
PremiumPress Releases
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy
4M ago
PRFX
PainReform reaches 50% enrollment in second part of Phase 3 trial of PRF-110
PremiumThe FlyPainReform reaches 50% enrollment in second part of Phase 3 trial of PRF-110
4M ago
PRFX
PainReform files to sell ordinary shares, no amount given
PremiumThe Fly
PainReform files to sell ordinary shares, no amount given
5M ago
PRFX
PainReform reports 2023 EPS ($7.14) vs. ($8.13) last year
PremiumThe Fly
PainReform reports 2023 EPS ($7.14) vs. ($8.13) last year
5M ago
PRFX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >